Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2022, page-31

I don’twant to get ahead of myself but I can’t help but compare 4DX and Promedicus andanticipate that once 4DMedical cements growing revenues – we should see somebig moves up in the share price.

	Company	4dx	Promedicus
1	What they do	4D Lung Scanning	Medical Imaging
2	Sales type	Software as a Service	Contracts
3	Customers	I-Med (our first one)	Multiple
4	Current Annual Revenue as at June 30 2022	$430,000**	$93 million
5	Market Cap	197 million	$5.6billion
6	Shares on issue	294 million	104 million
7	Share price	.63c	$54

** AndreasFouras has said this IMed deal could be worth $40 million in revenue to4DMedical in time. So, fair to say its significant.

He has previouslysaid that as the 4DMedical train starts to leave the station it will be slow(in terms of revenue) – no 1 off sugar hits in terms of $million-dollar contractannouncements (as is ProMedicus sales model). But when the train gets movingpeople will, over time be surprised by how fast this train can go (how quickly revenue can grow). He has alsomentioned a couple of times that he believes that 4DX should be a multi-billiondollar revenue company with greater than 90% gross margins. When I think aboutthe share price potential – the mind absolutely boggles!! So much to look forward to if these guys keep executing as they have to date.